Skip to main content
Anthony Gerardi

Anthony Gerardi
VP Corporate Development (M&A), Truven Health

Anthony Gerardi is a healthcare executive with a proven track record developing and deploying innovation strategies to drive organic growth and acquisitions, partnerships and strategic investments in healthcare IT, healthcare services, other healthcare segments and other industries. He worked globally with companies such Thomson Reuters (now Truven Health Analytics), SKT Telecom, and GE to develop innovation strategies, new offerings, and customer experiences in healthcare and other markets. His private equity career started at GE, as an investor he has successfully accelerated the growth of portfolio companies. Private equity investments included Insight Health, R2 acquired by Hologic and Bravo Health acquired by HealthSpring/Cigna.

Anthony has led colleagues and clients through the entire growth and innovation strategy process from research and ideation to implementation, including mergers and acquisitions and organic growth. This includes leading global teams to create innovation strategies and transform company cultures, developing new business models, brands, offerings, and customer experiences for public and private companies.

Anthony was the practice leader for Doblin, a leading innovation strategy firm, during its accelerated growth and sale to Monitor. Prior to Doblin he co-led the innovation and strategic private equity group for MetLife, improving performance of business units through innovation strategies, external strategic investments, and partnerships. His private equity background includes leading investments for MetLife, Divine, and General Electric (GE) with over $100 million of investment experience.

Anthony has accumulated a strong track record in healthcare as a strategist and active investor, using innovation strategies and design methods to improve performance and financial results through organic growth, acquisitions, partnerships and strategic investments.

Sessions

Deal-Flow Salon F
Bijan Salehizadeh (Navimed Capital), Anthony Gerardi (Truven Health), Michael Greeley (Flybridge Capital Partners)
Venture financing, M&A, and IPOs are now starting to become commonplace in the healthcare data & analytics and Health IT markets, becoming one of the fastest growing sectors for deal flow, and outpacing growth in more traditional drug development and medical device markets. What’s driving this trend, who will be the winners and losers, and where is the market headed? Read more.

For exhibition and sponsorship opportunities at Strata Rx conference, contact Sharon Pierce at (203) 304-9476 or spierce@oreilly.com

For information on trade opportunities with O'Reilly conferences email mediapartners
@oreilly.com

View a complete list of Strata Rx 2013 contacts